Buscador de publicaciones

 
 
 
 
 

Mostrando 346 a 360 de 1626 publicaciones.

  • Fernández-Rodríguez D, Regueiro A, Brugaletta S, Martín-Yuste V, Masotti M, Cequier A, Iñiguez A, Serra A, Hernández-Antolín R, Mainar V, Valgimigli M, Tespili M, den Heijer P, Bethencourt A, Vázquez N, Serruys PW, Sabaté M. Optimization in stent implantation by manual thrombus aspiration in ST-segment-elevation myocardial infarction: findings from the EXAMINATION trial. Circ Cardiovasc Interv 2014 Jun; 7(3): 294-300

    IF: 6.982, Cuartil: 1, Decil: 1

    Ver abstract

  • Cerrato E, Echavarria-Pinto M, Tandjung K, Macaya C, Escaned J. Optimizing vessel healing following drug eluting stent implantation with biodegradable polymer DES. Minerva Cardioangiol 2014 Oct; 62(5): 407-20

    IF: 0, Cuartil: 4

    Ver abstract

  • Abilleira S, Cardona P, Ribó M, Millán M, Obach V, Roquer J, Cánovas D, Martí-Fàbregas J, Rubio F, Alvarez-Sabín J, Dávalos A, Chamorro A, de Miquel MA, Tomasello A, Castaño C, Macho JM, Ribera A, Gallofré M. Outcomes of a contemporary cohort of 536 consecutive patients with acute ischemic stroke treated with endovascular therapy. Stroke 2014 Apr; 45(4): 1046-52

    IF: 6.018, Cuartil: 1, Decil: 1

    Ver abstract

  • Flores-Mateo G, Elosua R, Rodriguez-Blanco T, Basora-Gallisà J, Bulló M, Salas-Salvadó J, Martínez-González MA, Estruch R, Corella D, Fitó M, Fiol M, Arós F, Gómez-Gracia E, Subirana I, Lapetra J, Ruiz-Gutierrez V, Saez GT, Covas MI. Oxidative stress is associated with an increased antioxidant defense in elderly subjects: a multilevel approach. PLoS ONE 2014; 9(9): e105881

    IF: 3.534, Cuartil: 1

    Ver abstract

  • Gómez M, Molina L, Bruguera J, Sala J, Masiá R, Muñoz-Aguayo D, Tomás M, Heredia S, Blanchart G, Gaixas S, Vila J, Fitó M. Oxidized low-density lipoprotein antibodies in myocardial infarction patients without classical risk factors. J Cardiovasc Med (Hagerstown) 2014 May; 15(5): 417-22

    IF: 1.407, Cuartil: 3

    Ver abstract

  • Sayols-Baixeras S, Lluís-Ganella C, Lucas G, Elosua R. Pathogenesis of coronary artery disease: focus on genetic risk factors and identification of genetic variants. Appl Clin Genet 2014; 7: 15-32

    IF: 0

    Ver abstract

  • Ay H, Arsava EM, Andsberg G, Benner T, Brown RD, Chapman SN, Cole JW, Delavaran H, Dichgans M, Engström G, Giralt-Steinhauer E, Grewal RP, Gwinn K, Jern C, Jiménez-Conde J, Jood K, Katsnelson M, Kissela B, Kittner SJ, Kleindorfer DO, Labovitz DL, Lanfranconi S, Lee JM, Lehm M, Lemmens R, Levi C, Li L, Lindgren A, Markus HS, McArdle PF, Melander O, Norrving B, Peddareddygari LR, Pedersén A, Pera J, Rannikmäe K, Rexrode KM, Rhodes D, Rich SS, Roquer J, Rosand J, Rothwell PM, Rundek T, Sacco RL, Schmidt R, Schürks M, Seiler S, Sharma P, Slowik A, Sudlow C, Thijs V, Woodfield R, Worrall BB, Meschia JF. Pathogenic ischemic stroke phenotypes in the NINDS-stroke genetics network. Stroke 2014 Dec; 45(12): 3589-96

    IF: 6.018, Cuartil: 1, Decil: 1

    Ver abstract

  • Rial R, Hervas LS, Monux G, Galindo A, Martin A, Hernando M, Martinez I, Hernando A, Serrano FJ. Polidocanol foam stability in terms of its association with glycerin. Phlebology 2014 Jun; 29(5): 304-9

    IF: 1.458, Cuartil: 3

    Ver abstract

  • Catalán-Ramos A, Verdú JM, Grau M, Iglesias-Rodal M, del Val García JL, Consola A, Comín E. Population prevalence and control of cardiovascular risk factors: what electronic medical records tell us. Aten Primaria 2014 Jan; 46(1): 15-24

    IF: 0.957, Cuartil: 3

    Ver abstract

  • Massot A, Vivanco R, Principe A, Roquer J, Rocamora R. Post-authorisation study of eslicarbazepine as treatment for drug-resistant epilepsy: preliminary results. Neurologia 2014 Mar; 29(2): 94-101

    IF: 1.322, Cuartil: 3

    Ver abstract

  • Bodí V, Bonanad C, Ruiz-Nodar JM. Postconditioning or preconditioning, which should be promoted for protecting from ischemic reperfusion injury? Response to letter IJC-D-14-02875. Int. J. Cardiol. 2014 Oct; 176(3): 1383-4

    IF: 6.175, Cuartil: 1, Decil: 1

    Ver abstract

  • Ramos-Fernández E, Tajes M, Palomer E, Ill-Raga G, Bosch-Morató M, Guivernau B, Román-Dégano I, Eraso-Pichot A, Alcolea D, Fortea J, Núñez L, Paez A, Alameda F, Fernàndez-Busquets X, Lleó A, Elosua R, Boada M, Valverde MA, Muñoz FJ. Posttranslational nitro-glycative modifications of albumin in Alzheimer's disease: implications in cytotoxicity and amyloid-β peptide aggregation. J. Alzheimers Dis. 2014; 40(3): 643-57

    IF: 4.147, Cuartil: 2

    Ver abstract

  • Quintela AM, Jimenez R, Piqueras L, Gómez-Guzmán M, Haro J, Zarzuelo MJ, Cogolludo A, Sanz MJ, Toral M, Romero M, Perez-Vizcaino F, Duarte J. PPARβ activation restores the high glucose-induced impairment of insulin signalling in endothelial cells. Br. J. Pharmacol. 2014 Jun; 171(12): 3089-102

    IF: 0

    Ver abstract

  • Dellegrottaglie S, Garcia-Alvarez A, Guarini P, Perrone-Filardi P, Fuster V, Sanz J. Prevalence and severity of ventricular dysfunction in patients with HIV-related pulmonary arterial hypertension. Heart Lung 2014; 43(3): 256-61

    IF: 1.32, Cuartil: 3

    Ver abstract

  • Baena-Diez JM, Grau M, Forès R, Fernández-Bergés D, Elosua R, Sorribes M, Félix-Redondo FJ, Segura A, Rigo F, Cabrera de León A, Sanz H, Marrugat J, Sala J. Prevalence of atrial fibrillation and its associated factors in Spain: An analysis of 6 population-based studies. DARIOS Study. Rev Clin Esp 2014 Dec; 214(9): 505-12

    IF: 1.314, Cuartil: 3

    Ver abstract

Una iniciativa de

Ministerio de Economía y Competitividad Fondo Europeo de Desarrollo Regional IMIM - Parc de Salut Mar